In May 2025, a district court ruled that the FDA acted within its statutory authority in making that determination
Higher-risk features include recent initiation or dose escalation of Mounjaro, active gastrointestinal symptoms such as nausea or vomiting, known gastroparesis, higher maintenance doses, concurrent opioid use, and procedures with inherently higher aspiration risk
Medical researchers have discovered that semaglutide may reverse the debilitating tissue damage caused by osteoarthritis, the world's most common form of arthritis
The case studys pharmacological intervention was the administration of semaglutide following the standard titration protocol: the patient was first prescribed 0.25 mg subcutaneously once weekly in August 2024
Our pharmacists and compounding technicians take the time to understand what each individual needs, working closely with prescribers to get it right